ProfileGDS4718 / 241905_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 62% 47% 39% 47% 59% 50% 57% 35% 47% 48% 44% 56% 37% 48% 51% 52% 34% 59% 52% 79% 40% 43% 42% 58% 54% 40% 63% 77% 62% 48% 43% 48% 46% 39% 53% 34% 38% 43% 40% 43% 40% 48% 48% 51% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.2865862
GSM549102patient 115, normal, homogenized [OPG study]5.367547
GSM549104patient 119, normal, homogenized [OPG study]4.9174739
GSM549108patient 138, normal, homogenized [OPG study]5.3782747
GSM549119patient 077, normal, homogenized [OPG study]6.0719659
GSM549133patient 032, cancer, homogenized [OPG study]5.4443750
GSM549139patient 042, cancer, homogenized [OPG study]5.9503157
GSM549099patient 107, normal, homogenized [OPG study]4.7725735
GSM549109patient 139, normal, homogenized [OPG study]5.3939547
GSM549110patient 046, normal, homogenized [OPG study]5.4312448
GSM549114patient 063, normal, homogenized [OPG study]5.1236944
GSM549122patient 082, normal, homogenized [OPG study]5.8891256
GSM549134patient 033, cancer, homogenized [OPG study]4.8606937
GSM549136patient 036, cancer, homogenized [OPG study]5.3311148
GSM549140patient 044, cancer, homogenized [OPG study]5.5247851
GSM549111patient 047, normal, homogenized [OPG study]5.6324352
GSM549113patient 057, normal, homogenized [OPG study]4.6727834
GSM549132patient 031, cancer, homogenized [OPG study]6.0791259
GSM549137patient 038, cancer, homogenized [OPG study]5.6214452
GSM549142patient 047, cancer, homogenized [OPG study]7.5018379
GSM549100patient 110, normal, homogenized [OPG study]4.9983440
GSM549107patient 135, normal, homogenized [OPG study]5.0867143
GSM549115patient 068, normal, homogenized [OPG study]5.0093542
GSM549116patient 072, normal, homogenized [OPG study]6.0087458
GSM549120patient 078, normal, homogenized [OPG study]5.7230454
GSM549131patient 030, cancer, homogenized [OPG study]4.9491340
GSM549118patient 074, normal, homogenized [OPG study]6.3450563
GSM549129patient 027, cancer, homogenized [OPG study]7.5537577
GSM549123patient 088, normal, homogenized [OPG study]6.3020262
GSM549124patient 006, cancer, homogenized [OPG study]5.4163748
GSM549126patient 015, cancer, homogenized [OPG study]5.1133543
GSM549128patient 025, cancer, homogenized [OPG study]5.362648
GSM549103patient 117, normal, homogenized [OPG study]5.3702446
GSM549117patient 073, normal, homogenized [OPG study]4.9284439
GSM549138patient 041, cancer, homogenized [OPG study]5.6727953
GSM549141patient 045, cancer, homogenized [OPG study]4.6358634
GSM549130patient 028, cancer, homogenized [OPG study]4.9041338
GSM549101patient 111, normal, homogenized [OPG study]5.1546143
GSM549105patient 128, normal, homogenized [OPG study]4.9982340
GSM549106patient 134, normal, homogenized [OPG study]5.0897243
GSM549112patient 048, normal, homogenized [OPG study]4.9773740
GSM549125patient 011, cancer, homogenized [OPG study]5.3980548
GSM549127patient 024, cancer, homogenized [OPG study]5.4132948
GSM549135patient 035, cancer, homogenized [OPG study]5.5433651